Zobrazeno 1 - 10
of 105
pro vyhledávání: '"Mariana Petaccia De Macedo"'
Autor:
Luciana Beatriz Mendes Gomes, Renata Lazari Sandoval, Camila Bragança Xavier, Tatiana Strava Correa, Raquel Midori Koga Matuda, Zenaide Silva de Souza, Luiz Guilherme Cernaglia Aureliano de Lima, Mariana Petaccia de Macedo, Filomena Marino Carvalho, Daniele Assad Suzuki
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 1-9 (2024)
Malignant mixed müllerian tumor (MMMT) is a rare neoplasm, consisting of carcinomatous (epithelial) and sarcomatous (mesenchymal) components that most commonly arise in the endometrium and more infrequently in the ovaries, fallopian tube, cervix, an
Externí odkaz:
https://doaj.org/article/c7114bc99ed947dabb1548b4fbd062a6
Autor:
María A. Bravo-Garzón MD, MSc, Leticia Bornstein-Quevedo MD, MSc, Veridiana Pires de Camargo MD, Gayatri Sanku PhD, MPH, Angela Marie Jansen PhD, MHS, Mariana Petaccia de Macedo MD, PhD, Mariana Rico-Restrepo MD, Matías Chacón MD
Publikováno v:
Cancer Control, Vol 31 (2024)
Objectives • Gather a panel of Latin American experts in testing and treating BRAF -melanoma. • Describe the current landscape of BRAF -mutated melanoma in Latin America. • Outline the current gaps in testing and recommend improvements for test
Externí odkaz:
https://doaj.org/article/a6a5391faa3b4867bb9ff07e95fe0eae
Autor:
Mariana Petaccia de Macedo, Ellen Caroline Toledo Nascimento, Fernando Augusto Soares, Fernando Costa Santini, Felipe D’Almeida Costa, Isabela Werneck da Cunha, Rodrigo Ramella Munhoz, Pedro De Marchi, Thiago William Carnier Jorge, Kátia Ramos Moreira Leite
Publikováno v:
Clinical Pathology, Vol 16 (2023)
Oncogenic neurotrophic tropomyosin receptor kinase gene fusions occur in less than 1% of common cancers. These mutations have emerged as new biomarkers in cancer genomic profiling with the approval of selective drugs against tropomyosin receptor kina
Externí odkaz:
https://doaj.org/article/c608b264cfcf42a8b61f08fbb8e9d2c7
Autor:
Ana Carolina Vasconcellos Guedes Otsuka, Eduardo Bertolli, Mariana Petaccia de Macedo, Clovis Antonio Lopes Pinto, João Pedreira Duprat Neto
Publikováno v:
Anais Brasileiros de Dermatologia, Vol 97, Iss 5, Pp 583-591 (2022)
Abstract Background: Basal cell and squamous cell carcinomas (BCC and SCC) are the most common types of cancer worldwide. Intraoperative assessment of surgical margins by frozen section has been widely used to ensure disease-free margins. The intraop
Externí odkaz:
https://doaj.org/article/35a2539ed20847cb818d98c15e88a510
Autor:
Reinaldo Tovo Filho, MD, PhD, Silmara da Costa Pereira Cestari, MD, PhD, Isabella Zurita Dehó, MD, Reinaldo Falavigna Tovo, PhD, Gabriela Franco Marques, MD, PhD, Ivana Diniz Lírio, MD, Mariana Petaccia de Macedo, MD
Publikováno v:
JAAD Case Reports, Vol 18, Iss , Pp 89-93 (2021)
Externí odkaz:
https://doaj.org/article/34d3da4070454900affe8a137275302c
Autor:
Renata Lazari Sandoval, Cibele Masotti, Mariana Petaccia de Macedo, Maurício Fernando Silva Almeida Ribeiro, Ana Carolina Rathsam Leite, Sibele Inacio Meireles, Rodrigo Medeiros Bovolin, Fernando Costa Santini, Rodrigo Ramella Munhoz, Denis Leonardo Fontes Jardim, Artur Katz, Anamaria Aranha Camargo, Gustavo dos Santos Fernandes, Maria Isabel Achatz
Publikováno v:
JCO Global Oncology, Vol , Iss 7, Pp 1141-1150 (2021)
PURPOSELi-Fraumeni syndrome (LFS) is rare in the worldwide population, but it is highly prevalent in the Brazilian population because of a founder mutation, TP53 p.R337H, accounting for 0.3% of south and southeastern population. Clinical criteria for
Externí odkaz:
https://doaj.org/article/6a8c6059217b4076af1e7479ce18af74
Autor:
Saulo Brito Silva, Carlos Wagner S. Wanderley, José Flavio Gomes Marin, Mariana Petaccia de Macedo, Ellen Caroline Toledo do Nascimento, Fernanda Frozoni Antonacio, Caroline Sales Figueiredo, Mateus Trinconi Cunha, Fernando Q. Cunha, Gilberto de Castro Junior
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Background: A significant proportion of patients with non-small-cell lung cancer (NSCLC) do not respond to immune checkpoint inhibitors (ICIs). Since metabolic reprogramming with increased glycolysis is a hallmark of cancer and is involved in immune
Externí odkaz:
https://doaj.org/article/21b9dc841f9f476aaeccc1bd673df974
Autor:
Isabela Werneck da Cunha, Renata de Almeida Coudry, Mariana Petaccia de Macedo, Emilio Augusto Campos Pereira de Assis, Stephen Stefani, Fernando Augusto Soares
Publikováno v:
Surgical and Experimental Pathology, Vol 4, Iss 1, Pp 1-27 (2021)
Abstract Background Adoption of molecular pathology in Brazil is currently very limited. Of note, there are no programs for training new molecular pathologists in the country; thus, documents compiling nationally applicable information on molecular p
Externí odkaz:
https://doaj.org/article/dab21f75143d4a3f95b646777d0879bd
Autor:
Maurício Fernando Silva Almeida Ribeiro, Luiza Lara Gadotti, Karina Perez Sacardo, Carlos Diego Holanda Lopes, Rodrigo Saddi, João Victor Machado Alessi, Mariana Petaccia de Macedo, Ellen Caroline Toledo do Nascimento, Leonardo de Abreu Testagrossa, Artur Katz
Publikováno v:
SAGE Open Medical Case Reports, Vol 10 (2022)
Chromosomal rearrangements involving the c-ros oncogene 1 ( ROS1 ) gene define a subset of non-small cell lung cancers highly sensitive to small-molecule tyrosine kinase inhibitors. However, little is known about the impact of different fusion partne
Externí odkaz:
https://doaj.org/article/28466b5038404de88eabd4d79f59b59e
Autor:
Amanda Zorzetto Antonialli, Eduardo Bertolli, Mariana Petaccia de Macedo, Clovis Antonio Lopes Pinto, Vinicius Fernando Calsavara, João Pedreira Duprat Neto
Publikováno v:
Anais Brasileiros de Dermatologia, Vol 95, Iss 6, Pp 691-695 (2020)
Abstract Background: The mitotic index is no longer used to classify T1 melanoma patients into T1a and T1b, so it should not be used to indicate sentinel node biopsy in these patients. Objectives: To evaluate patients with T1 melanoma who underwent s
Externí odkaz:
https://doaj.org/article/1a0b303a51a9454dac4de7b37d096081